Hanmi Pharm. Co., Ltd.
Simbolis: 128940.KS
KSC
322000
KRWRinkos kaina šiandien
24.3478
P/E santykis
0.0155
PEG koeficientas
4.09T
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Hanmi Pharm. Co., Ltd. (128940-KS) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 254155.7 | 236736.4 | 211734.4 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 199175.4 | 89407.8 | 2509.7 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 179195.9 | 191163.2 | 241982 | ||||||||||||||
balance-sheet.row.inventory | 0 | 288813.8 | 266185.4 | 250188.7 | ||||||||||||||
balance-sheet.row.other-current-assets | 0 | 26487.6 | 73.2 | 56.5 | ||||||||||||||
balance-sheet.row.total-current-assets | 0 | 748652.9 | 694158.3 | 703961.6 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 860242 | 917981.5 | 957218.2 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.long-term-investments | 0 | 47756 | -17742 | 50416.9 | ||||||||||||||
balance-sheet.row.tax-assets | 0 | 159972 | 89901.6 | 91855.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 54367 | 155699.5 | 53106.5 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1203382.2 | 1230427.5 | 1232767.1 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.account-payables | 0 | 45180.3 | 39709.5 | 42833.4 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 483775.4 | 489193 | 455166.9 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 6741.6 | 22180.1 | 26475 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 82028.4 | 225815.6 | 301099.8 | ||||||||||||||
Deferred Revenue Non Current | 0 | 1033.1 | 8457.6 | 10839.7 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0 | 150970.5 | 131195.3 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 146408.2 | 238610.7 | 359531 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 7063.4 | 48215.1 | 65622.2 | ||||||||||||||
balance-sheet.row.total-liab | 0 | 851824.4 | 915359 | 1008469.3 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 0 | 31405.4 | 30794.9 | 30195.7 | ||||||||||||||
balance-sheet.row.retained-earnings | 0 | 336059.3 | 452297.5 | 396915.9 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 216059.6 | 232729.4 | 200479.4 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 371918.2 | 156043.8 | 175322.8 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 955442.4 | 871865.6 | 802913.7 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 144768.3 | 137361.1 | 125345.7 | ||||||||||||||
balance-sheet.row.total-equity | 0 | 1100210.6 | 1009226.7 | 928259.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||
Total Investments | 0 | 246931.4 | 71665.7 | 52926.7 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 572867.3 | 715008.6 | 756266.7 | ||||||||||||||
balance-sheet.row.net-debt | 0 | 517886.9 | 567680 | 547042.1 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 146231.2 | 101558.2 | 81478.2 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 98454 | 96842 | 89086.3 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -57396.6 | -73686.3 | -53516.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -2602.8 | 38190.1 | -74313.9 | ||||||||||||||
cash-flows.row.inventory | 0 | -16902.6 | -14365.3 | 18915.7 | ||||||||||||||
cash-flows.row.account-payables | 0 | 5574.2 | -2736.1 | 9794.1 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -43465.5 | -94774.9 | -7912.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 29249.1 | 37555 | 84874.8 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 2600.2 | -25772 | -14112.3 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -94770.2 | -92923.2 | -7738.6 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 90377.5 | 86.6 | 785.9 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | -133933.2 | -13206.4 | 12101.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -183472.2 | -181408.1 | -43388.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -103371 | -260971.4 | -232371.4 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 93.5 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3070.6 | -3834.1 | -4873.5 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | -17995.6 | -5992.2 | -5881.3 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2443 | 233930.9 | 129795.6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -126786.7 | -36866.8 | -113330.6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1372.9 | -5890 | 17863.5 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -92348.3 | -61896 | 63067.3 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 54980.3 | 147328.7 | 209224.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 147328.7 | 209224.6 | 146157.4 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 216537.6 | 162268.9 | 201923.2 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | 168791.1 | 112675.9 | 167498.3 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1490887.5 | 1331546.6 | 1203185.7 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 655030.7 | 612993.5 | 570433.4 | ||||||||||||||
income-statement-row.row.gross-profit | 0 | 835856.7 | 718553.1 | 632752.2 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.operating-expenses | 0 | 610971.8 | 560462.7 | 507336.4 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1266002.5 | 1173456.3 | 1077769.8 | ||||||||||||||
income-statement-row.row.interest-income | 0 | 4617.7 | 7856.4 | 5722.3 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 98454 | 97942.5 | 87056.1 | ||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 0 | 224884.9 | 158090.3 | 125415.9 | ||||||||||||||
income-statement-row.row.income-before-tax | 0 | 195267.6 | 121012.5 | 103696.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 28600.6 | 19454.3 | 22218.3 | ||||||||||||||
income-statement-row.row.net-income | 0 | 146231.2 | 82791.7 | 67025.4 |
Dažnai užduodami klausimai
Kas yra Hanmi Pharm. Co., Ltd. (128940.KS) bendras turtas?
Hanmi Pharm. Co., Ltd. (128940.KS) bendras turtas yra 1952035090968.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.671.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 13515.617.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.108.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.158.
Kas yra Hanmi Pharm. Co., Ltd. (128940.KS) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 146231157740.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 572867266550.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 610971802715.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.